Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Drug: 5 mg bgm0504's trials
A Study of BGM0504 in Participants with Type 2 Diabetes
Drug: 5 mg BGM0504 Administered SC
Ongoing
Recruiting
Phase 3
Open NCT06716216 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
